HALO
Halozyme Therapeutics, Inc. · Healthcare
SVP and CFO Nicole Labrosse sold $124K of Halozyme Therapeutics, Inc.
Sold$124,382
$49.26Price
2,525Shares
−22%Stake
What HALO did after the filing
- The stock from Tue, Feb 21 close, $49.66
- −24.5%
- S&P 500, same days
- +2.8%
Measured over 30 trading days, to the Apr 4 close.
Traded Thu, Feb 16. Filed Tue, Feb 21, 2:00 PM ET, during the session. Returns use the Feb 21 close and the Apr 4 close. Not investment advice.